scholarly journals 2020 Russian and European clinical practice guidelines for the management of NSTEMI patients: have approaches to antithrombotic therapy been simplified?

2021 ◽  
Vol 10 (2) ◽  
pp. 92-101
Author(s):  
O. L. Barbarash ◽  
V. V. Kashtalap
Keyword(s):  
Clinical Practice ◽  
Anticoagulant Therapy ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Antithrombotic Therapy ◽  
St Segment Elevation ◽  
Coronary Syndrome ◽  
St Segment ◽  
Coronary Syndromes ◽  
Esc Guidelines

Highlights. Prescribtion patterns of antithrombotic therapy in patients with non-ST-segment elevation acute coronary syndromes have been comapred in 2020 Russian and European clinical practice guidelines for the management of NSTEMI patients.A comparative assessment of novel approaches of antiplatelet and anticoagulant therapy recommended in 2020 European and Russian clinical practice guidelines for the management of patients with non-ST-segment elevation acute coronary syndrome is reported. In prescribing antiplatelet therapy, ESC guidelines suggest focusing attention on a more complex set of regimens to balance ischemic and hemorrhagic risks. Approaches to prescribing anticoagulant therapy do not differ in the recommendations of two medical societies. Fondaparinux has compelling advantages over other drugs regarding the combination of efficacy and safety in patients.

scholarly journals 2020 Clinical practice guidelines for Acute coronary syndrome without ST segment elevation

2021 ◽  
Vol 26 (4) ◽  
pp. 4449
Author(s):  
Russian Society of Cardiology (RSC)
Keyword(s):  
Acute Coronary Syndrome ◽  
Clinical Practice ◽  
Russian Federation ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Ministry Of Health ◽  
St Segment Elevation ◽  
Coronary Syndrome ◽  
St Segment ◽  
The Russian Federation

Endorsed by: Research and Practical Council of the Ministry of Health of the Russian Federation.

scholarly journals 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation: what is new for neurologists?

2021 ◽  
Vol 27 (1) ◽  
pp. 7-15
Author(s):  
S. N. Yanishevskiy ◽  
I. B. Skiba ◽  
A. Y. Polushin
Keyword(s):  
Atrial Fibrillation ◽  
Clinical Practice ◽  
Anticoagulant Therapy ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Cryptogenic Stroke ◽  
Original Position ◽  
Diagnosis And Management ◽  
Esc Guidelines ◽  
European Society Of Cardiology

Clinical practice guidelines for the diagnosis and management of atrial fibrillation (AF) are one of the most regularly updated documents by the European Society of Cardiology. The new version of clinical practice guidelines (2020) contains a number of changes regarding anticoagulant therapy in patients with AF who have developed acute cerebrovascular accidents. In this review, we discuss the statements of the updated document on the timing of the start/restart of anticoagulant therapy after ischemic stroke and intracranial hemorrhage in patients with AF, the choice of antithrombotic therapy in patients with cryptogenic stroke, as well as the need for the additional testing to clarify the origin of the embolism. We provide our original position on the possibility of applying these recommendations to the real clinical practice.

scholarly journals Critical appraisal of the 2020 ESC guideline recommendations on diagnosis and risk assessment in patients with suspected non-ST-segment elevation acute coronary syndrome

2021 ◽  
Author(s):  
Evangelos Giannitsis ◽  
Stefan Blankenberg ◽  
Robert H. Christenson ◽  
Norbert Frey ◽  
Stephan von Haehling ◽  
...  
Keyword(s):  
Acute Coronary Syndromes ◽  
Critical Appraisal ◽  
Scientific Evidence ◽  
St Segment Elevation ◽  
Coronary Syndrome ◽  
Scientific Support ◽  
Prognostic Assessment ◽  
St Segment ◽  
Coronary Syndromes ◽  
Esc Guidelines

AbstractMultiple new recommendations have been introduced in the 2020 ESC guidelines for the management of acute coronary syndromes with a focus on diagnosis, prognosis, and management of patients presenting without persistent ST-segment elevation. Most recommendations are supported by high-quality scientific evidence. The guidelines provide solutions to overcome obstacles presumed to complicate a convenient interpretation of troponin results such as age-, or sex-specific cutoffs, and to give practical advice to overcome delays of laboratory reporting. However, in some areas, scientific support is less well documented or even missing, and other areas are covered rather by expert opinion or subjective recommendations. We aim to provide a critical appraisal on several recommendations, mainly related to the diagnostic and prognostic assessment, highlighting the discrepancies between Guideline recommendations and the existing scientific evidence.

Sign in / Sign up

Export Citation Format

Share Document